KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.26 Million USD | 4.74% |
| 2022 | -10.78 Million USD | -53.37% |
| 2021 | -7.02 Million USD | -460.22% |
| 2020 | -1.25 Million USD | -314.24% |
| 2019 | 585.67 Thousand USD | -49.71% |
| 2018 | 1.16 Million USD | -21.52% |
| 2017 | 1.48 Million USD | 301.54% |
| 2016 | -736.25 Thousand USD | -162.32% |
| 2015 | 1.18 Million USD | 2.96% |
| 2014 | 1.14 Million USD | 13.87% |
| 2013 | 1 Million USD | -5.15% |
| 2012 | 1.06 Million USD | -17.59% |
| 2011 | 1.28 Million USD | 7.89% |
| 2010 | 1.19 Million USD | 65.6% |
| 2009 | 721.51 Thousand USD | -7.38% |
| 2008 | 779.01 Thousand USD | 302.57% |
| 2007 | 193.5 Thousand USD | 974.18% |
| 2006 | -22.13 Thousand USD | 74.92% |
| 2005 | -88.25 Thousand USD | 75.44% |
| 2004 | -359.35 Thousand USD | -46.29% |
| 2003 | -245.63 Thousand USD | 2.74% |
| 2002 | -252.55 Thousand USD | 32.52% |
| 2001 | -374.26 Thousand USD | -265.66% |
| 2000 | -102.35 Thousand USD | 56.88% |
| 1999 | -237.33 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.19 Million USD | 39.22% |
| 2024 Q1 | -1.96 Million USD | 10.75% |
| 2023 FY | -10.26 Million USD | 4.74% |
| 2023 Q3 | -1.79 Million USD | 44.46% |
| 2023 Q2 | -3.22 Million USD | -5.49% |
| 2023 Q4 | -2.19 Million USD | -22.7% |
| 2023 Q1 | -3.05 Million USD | -21.72% |
| 2022 Q4 | -2.51 Million USD | -64.2% |
| 2022 Q2 | -3.61 Million USD | -15.57% |
| 2022 Q3 | -1.52 Million USD | 57.67% |
| 2022 Q1 | -3.12 Million USD | -47.95% |
| 2022 FY | -10.78 Million USD | -53.37% |
| 2021 FY | -7.02 Million USD | -460.22% |
| 2021 Q1 | -2.21 Million USD | -90.07% |
| 2021 Q2 | -1.38 Million USD | 37.6% |
| 2021 Q4 | -2.11 Million USD | -59.84% |
| 2021 Q3 | -1.32 Million USD | 4.27% |
| 2020 FY | -1.25 Million USD | -314.24% |
| 2020 Q3 | 358.82 Thousand USD | 134.77% |
| 2020 Q4 | -1.16 Million USD | -424.51% |
| 2020 Q1 | 582.82 Thousand USD | 465.08% |
| 2020 Q2 | -1.03 Million USD | -277.07% |
| 2019 Q4 | -159.64 Thousand USD | -119.36% |
| 2019 FY | 585.67 Thousand USD | -49.71% |
| 2019 Q3 | 824.48 Thousand USD | 2198.02% |
| 2019 Q2 | 35.87 Thousand USD | 131.19% |
| 2019 Q1 | -115.03 Thousand USD | 73.63% |
| 2018 Q3 | 482.68 Thousand USD | -21.77% |
| 2018 FY | 1.16 Million USD | -21.52% |
| 2018 Q4 | -436.29 Thousand USD | -190.39% |
| 2018 Q1 | 501.12 Thousand USD | -27.9% |
| 2018 Q2 | 617.01 Thousand USD | 23.12% |
| 2017 Q4 | 695.06 Thousand USD | 77.14% |
| 2017 Q2 | 190.34 Thousand USD | 240.76% |
| 2017 Q1 | -135.22 Thousand USD | -20.23% |
| 2017 FY | 1.48 Million USD | 301.54% |
| 2017 Q3 | 392.37 Thousand USD | 106.14% |
| 2016 FY | -736.25 Thousand USD | -162.32% |
| 2016 Q1 | 463.25 Thousand USD | 59.62% |
| 2016 Q4 | -112.46 Thousand USD | 5.45% |
| 2016 Q3 | -118.95 Thousand USD | 67.81% |
| 2016 Q2 | -369.6 Thousand USD | -179.78% |
| 2015 Q4 | 290.21 Thousand USD | -42.73% |
| 2015 Q3 | 506.78 Thousand USD | 742.6% |
| 2015 Q2 | -78.86 Thousand USD | -117.42% |
| 2015 Q1 | 452.79 Thousand USD | 236.82% |
| 2015 FY | 1.18 Million USD | 2.96% |
| 2014 Q3 | 319.06 Thousand USD | 32.34% |
| 2014 Q4 | 134.43 Thousand USD | -57.87% |
| 2014 FY | 1.14 Million USD | 13.87% |
| 2014 Q1 | 506.38 Thousand USD | 110.46% |
| 2014 Q2 | 241.09 Thousand USD | -52.39% |
| 2013 Q4 | 240.61 Thousand USD | 77.48% |
| 2013 Q2 | 125.09 Thousand USD | -56.4% |
| 2013 FY | 1 Million USD | -5.15% |
| 2013 Q1 | 286.89 Thousand USD | 228.29% |
| 2013 Q3 | 135.57 Thousand USD | 8.37% |
| 2012 Q2 | 146.12 Thousand USD | -73.53% |
| 2012 Q4 | 87.39 Thousand USD | -83.88% |
| 2012 Q3 | 541.99 Thousand USD | 270.92% |
| 2012 FY | 1.06 Million USD | -17.59% |
| 2012 Q1 | 552.11 Thousand USD | 144.09% |
| 2011 FY | 1.28 Million USD | 7.89% |
| 2011 Q1 | 589.44 Thousand USD | 103.04% |
| 2011 Q2 | 331.96 Thousand USD | -43.68% |
| 2011 Q3 | 178.88 Thousand USD | -46.11% |
| 2011 Q4 | 226.19 Thousand USD | 26.45% |
| 2010 Q2 | 136.03 Thousand USD | -57.58% |
| 2010 FY | 1.19 Million USD | 65.6% |
| 2010 Q4 | 290.31 Thousand USD | 62.16% |
| 2010 Q1 | 320.66 Thousand USD | 194.76% |
| 2010 Q3 | 179.02 Thousand USD | 31.6% |
| 2009 Q4 | 108.78 Thousand USD | -43.71% |
| 2009 FY | 721.51 Thousand USD | -7.38% |
| 2009 Q1 | 204.35 Thousand USD | 1.86% |
| 2009 Q3 | 193.24 Thousand USD | 95.55% |
| 2009 Q2 | 98.82 Thousand USD | -51.64% |
| 2008 Q2 | 76.38 Thousand USD | -45.2% |
| 2008 Q1 | 139.4 Thousand USD | 72.51% |
| 2008 FY | 779.01 Thousand USD | 302.57% |
| 2008 Q4 | 200.63 Thousand USD | -32.62% |
| 2008 Q3 | 297.78 Thousand USD | 289.83% |
| 2007 FY | 193.5 Thousand USD | 974.18% |
| 2007 Q3 | 69.8 Thousand USD | 174.65% |
| 2007 Q4 | 80.8 Thousand USD | 15.76% |
| 2007 Q2 | -93.5 Thousand USD | -284.85% |
| 2007 Q1 | 50.58 Thousand USD | 99.27% |
| 2006 Q1 | -111.11 Thousand USD | -220.8% |
| 2006 Q3 | 19.69 Thousand USD | 116.72% |
| 2006 Q4 | 25.38 Thousand USD | 28.88% |
| 2006 FY | -22.13 Thousand USD | 74.92% |
| 2006 Q2 | -117.8 Thousand USD | -6.02% |
| 2005 Q2 | -129.76 Thousand USD | 25.6% |
| 2005 FY | -88.25 Thousand USD | 75.44% |
| 2005 Q4 | 91.98 Thousand USD | 476.94% |
| 2005 Q3 | -24.4 Thousand USD | 81.2% |
| 2005 Q1 | -174.42 Thousand USD | -54.29% |
| 2004 FY | -359.35 Thousand USD | -46.29% |
| 2004 Q2 | 12.48 Thousand USD | 113.1% |
| 2004 Q3 | -84.35 Thousand USD | -775.85% |
| 2004 Q4 | -113.05 Thousand USD | -34.02% |
| 2004 Q1 | -95.29 Thousand USD | -42.72% |
| 2003 Q1 | -155.22 Thousand USD | -358.88% |
| 2003 FY | -245.63 Thousand USD | 2.74% |
| 2003 Q4 | -66.77 Thousand USD | -4.22% |
| 2003 Q3 | -64.07 Thousand USD | -228.61% |
| 2003 Q2 | -19.49 Thousand USD | 87.44% |
| 2002 FY | -252.55 Thousand USD | 32.52% |
| 2002 Q4 | -33.82 Thousand USD | -183.95% |
| 2002 Q3 | -11.91 Thousand USD | 74.97% |
| 2002 Q2 | -47.58 Thousand USD | 56.28% |
| 2002 Q1 | -108.83 Thousand USD | -13.62% |
| 2001 Q1 | -120.32 Thousand USD | -599.37% |
| 2001 FY | -374.26 Thousand USD | -265.66% |
| 2001 Q4 | -95.78 Thousand USD | -53.69% |
| 2001 Q3 | -62.32 Thousand USD | 41.92% |
| 2001 Q2 | -107.31 Thousand USD | 10.82% |
| 2000 FY | -102.35 Thousand USD | 56.88% |
| 2000 Q2 | 10 Thousand USD | 0.0% |
| 2000 Q4 | -17.2 Thousand USD | -168.33% |
| 2000 Q3 | 25.17 Thousand USD | 151.73% |
| 1999 FY | -237.33 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 82.191% |
| AngioDynamics, Inc. | -97.71 Million USD | 89.49% |
| AtriCure, Inc. | -26.68 Million USD | 61.511% |
| Avinger, Inc. | -16.63 Million USD | 38.263% |
| Azenta, Inc. | -73.12 Million USD | 85.956% |
| BioLife Solutions, Inc. | -70.82 Million USD | 85.5% |
| The Cooper Companies, Inc. | 533.1 Million USD | 101.926% |
| Daxor Corporation | -177.07 Thousand USD | -5699.79% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 32.041% |
| Femasys Inc. | -14.5 Million USD | 29.214% |
| GlucoTrack, Inc. | -7.1 Million USD | -44.566% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 642.238% |
| Hologic, Inc. | 882.6 Million USD | 101.164% |
| ICU Medical, Inc. | 22.82 Million USD | 144.994% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.581% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 127.695% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -48.829% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -48.829% |
| Masimo Corporation | 136.5 Million USD | 107.524% |
| Microbot Medical Inc. | -9.85 Million USD | -4.211% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 169.983% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 108.286% |
| Nephros, Inc. | -1.59 Million USD | -544.694% |
| NovoCure Limited | -232.87 Million USD | 95.59% |
| NEXGEL, Inc. | -3.47 Million USD | -195.369% |
| NEXGEL, Inc. | -3.47 Million USD | -195.369% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 90.01% |
| OraSure Technologies, Inc. | 54.07 Million USD | 118.991% |
| Pro-Dex, Inc. | 7.17 Million USD | 243.176% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 76.431% |
| Predictive Oncology Inc. | -13.92 Million USD | 26.228% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -276.972% |
| QuidelOrtho Corporation | 139.1 Million USD | 107.383% |
| Repligen Corporation | 54.57 Million USD | 118.818% |
| Sanara MedTech Inc. | -4.21 Million USD | -143.644% |
| STAAR Surgical Company | 28.09 Million USD | 136.552% |
| Sharps Technology, Inc. | -10.12 Million USD | -1.415% |
| Utah Medical Products, Inc. | 16.77 Million USD | 161.215% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 87.918% |
| Jin Medical International Ltd. | 2.86 Million USD | 458.181% |